Phase I trial of prophylactic rituximab for the prevention of post transplant Epstein-Barr related lymphoproliferative disease (EBV-PTLD) following T cell depleted (TCD) unrelated or HLA-mismatched related hematopoietic cell transplantation (HCT): Efficacy, toxicity, and effect on subsequent B cell reconstitution Meeting Abstract

  

Authors:	Small, T. N.; Kernan, N. A.; Jakubowski, A. A.; Knowles, M. A.; Young, J. W.; Castro-Malaspina, H.; Prockop, S. E.; O'Reilly, R. J.; Papadopoulos, E. B.
Abstract Title:	Phase I trial of prophylactic rituximab for the prevention of post transplant Epstein-Barr related lymphoproliferative disease (EBV-PTLD) following T cell depleted (TCD) unrelated or HLA-mismatched related hematopoietic cell transplantation (HCT): Efficacy, toxicity, and effect on subsequent B cell reconstitution
Meeting Title:	53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis
Journal Title:	Blood
Volume:	118
Issue:	21
Meeting Dates:	2011 Dec 10-13
Meeting Location:	San Diego, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2011-11-01
Start Page:	860
Language:	English
ACCESSION:	WOS:000299597102566
PROVIDER:	wos
DOI:	10.1182/blood.V118.21.1971.1971
Notes:	--- - Meeting Abstract: 1971 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis - DEC 10-13, 2011 - San Diego, CA - "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/40102